University of Sussex
Browse

File(s) not publicly available

The pharmaceutical industry and access and benefit-sharing

presentation
posted on 2023-06-08, 06:48 authored by Florian Kern
My contribution is based on an analysis of the voluntary realisation of the Access and Benfit-Sharing (ABS) stipulations of the UN Convention on Biological Diversity (CBD) by the pharmaceutical industry. Our research shows that on a voluntary basis the pharmaceutical industry realises ABS provisions of the CBD only to a very limited extent. We thus argue for the necessity of an legally binding ABS protocol on the basis of the Bonn guidelines.

History

Publication status

  • Published

Publisher

Federal Agency for Nature Conservation, Germany

Pages

3.0

Presentation Type

  • paper

Event name

European Regional Meeting on an Internationally Recognized Certificate of Origin / Source / Legal Provenance

Event location

Isle of Vilm, Germany.

Event type

conference

Event date

24 - 29 October 2006.

Department affiliated with

  • SPRU - Science Policy Research Unit Publications

Full text available

  • No

Peer reviewed?

  • Yes

Editors

F Wolff, U Feit

Legacy Posted Date

2012-02-06

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC